Thinking of joining a study?

Register your interest

NCT06872567 | RECRUITING | Knee Osteoarthritis (Knee OA)


Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Sponsor:

North American Science Associates Ltd.

Brief Summary:

Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection

Condition or disease

Osteoarthritis (OA Knee)

Intervention/treatment

genicular artery embolization

Corticosteroid Injection

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 126 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Resorbable Embolization MicroSpheres for OsteoaRthritis Benefit
Actual Study Start Date : 2025-10-01
Estimated Primary Completion Date : 2026-06
Estimated Study Completion Date : 2026-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 40 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patient has localized knee pain
  • * Must be an appropriate candidate for arterial vascular access procedure
Exclusion Criteria
  • * Known sensitivity or allergy to implant materials
  • * Unable or unwilling to comply with study requirements

Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain

Location Details

NCT06872567


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Virginia

University of Virginia

Charlottesville, Virginia, United States, 22903

Loading...